Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
atai and Beckley Psytech plan to meet with the U.S. Food and Drug Administration (FDA) and other regulatory agencies to finalize the Phase 3 trial design.
Extended lab space for product development, customer demos, and training
The proceeds from the QIP will be utiized for purchase of outstanding optionally convertible debentures
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
Dilip Shanghvi to continue as the Executive Chairman of the Board
The acquisition sets up the foundation for a central hub of GMP value-added services and greater access to new customers in the rapidly growing Biopharma market
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
his is the second license extension of a Nurix autoimmune disease program by Sanofi in the last 90 days
Subscribe To Our Newsletter & Stay Updated
